Corrigendum to "efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial" [Res Med 108 (2014) 41-49]

Jan Lötvall; Eugene R. Bleecker; William W. Busse; Paul M. O'Byrne; Ashley Woodcock; Edward M. Kerwin; Sally Stone; Richard Forth; Loretta Jacques; Eric D. Bateman

doi:10.1016/j.rmed.2014.10.014

Corrigendum to "efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial" [Res Med 108 (2014) 41-49]

Jan Lötvall, Eugene R. Bleecker, William W. Busse, Paul M. O'Byrne, Ashley Woodcock, Edward M. Kerwin, Sally Stone, Richard Forth, Loretta Jacques, Eric D. Bateman

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	146
Number of pages	1
Journal	Respiratory Medicine
Volume	109
Issue number	1
DOIs	https://doi.org/10.1016/j.rmed.2014.10.014
State	Published - Jan 1 2015
Externally published	Yes

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/j.rmed.2014.10.014

Cite this

Lötvall, J., Bleecker, E. R., Busse, W. W., O'Byrne, P. M., Woodcock, A., Kerwin, E. M., Stone, S., Forth, R., Jacques, L., & Bateman, E. D. (2015). Corrigendum to "efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial" [Res Med 108 (2014) 41-49]. Respiratory Medicine, 109(1), 146. https://doi.org/10.1016/j.rmed.2014.10.014

Corrigendum to "efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial" [Res Med 108 (2014) 41-49]. / Lötvall, Jan; Bleecker, Eugene R.; Busse, William W. et al.
In: Respiratory Medicine, Vol. 109, No. 1, 01.01.2015, p. 146.

Research output: Contribution to journal › Comment/debate › peer-review

Lötvall, J, Bleecker, ER, Busse, WW, O'Byrne, PM, Woodcock, A, Kerwin, EM, Stone, S, Forth, R, Jacques, L & Bateman, ED 2015, 'Corrigendum to "efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial" [Res Med 108 (2014) 41-49]', Respiratory Medicine, vol. 109, no. 1, pp. 146. https://doi.org/10.1016/j.rmed.2014.10.014

@article{239c71cf58254b82b941f54a8daa2257,

title = "Corrigendum to {"}efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial{"} [Res Med 108 (2014) 41-49]",

author = "Jan L{\"o}tvall and Bleecker, {Eugene R.} and Busse, {William W.} and O'Byrne, {Paul M.} and Ashley Woodcock and Kerwin, {Edward M.} and Sally Stone and Richard Forth and Loretta Jacques and Bateman, {Eric D.}",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/j.rmed.2014.10.014",

language = "English (US)",

volume = "109",

pages = "146",

journal = "Respiratory Medicine",

issn = "0954-6111",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Corrigendum to "efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma

T2 - A 24-week placebo and active-controlled randomised trial" [Res Med 108 (2014) 41-49]

AU - Lötvall, Jan

AU - Bleecker, Eugene R.

AU - Busse, William W.

AU - O'Byrne, Paul M.

AU - Woodcock, Ashley

AU - Kerwin, Edward M.

AU - Stone, Sally

AU - Forth, Richard

AU - Jacques, Loretta

AU - Bateman, Eric D.

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84919741338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919741338&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2014.10.014

DO - 10.1016/j.rmed.2014.10.014

M3 - Comment/debate

AN - SCOPUS:84919741338

SN - 0954-6111

VL - 109

SP - 146

JO - Respiratory Medicine

JF - Respiratory Medicine

IS - 1

ER -

Corrigendum to "efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial" [Res Med 108 (2014) 41-49]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this